GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (FRA:9LB) » Definitions » Interest Received

Legend Biotech (FRA:9LB) Interest Received


View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.


Legend Biotech Business Description

Traded in Other Exchanges
Address
2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.